PREVIOUS ARTICLENEXT ARTICLE NEWS
Project Fiona turns headsBy Ryan Noik 13 January 2012 | Categories: news
One of the new innovations turning heads and raising eyebrows at the Consumer Electronics Show is Project Fiona, a hybrid PC-gaming tablet machine by Razer.
The device is certainly distinctive, consisting of a 10” touchscreen with two controllers on either side that resemble the PlayStation Move navigation controller.
However, Project Fiona sports a Core i7 CPU and runs Windows 7, in a bid to offer a PC gaming experience on its tablet sized screen. Although further details, such as what GPU is onboard and hard drive size, are yet to be revealed, the concept is interesting enough, if only due to the fact that it will apparently cater to games that have not been adapted for tablets as yet, such as Assassin’s Creed Revelations.
“While multi-touchscreens have become the de facto user interface for tablets, they are not the right interface for serious PC gaming,” explained Min-Liang Tan, Razer’s chief executive officer.
“The user interface we have designed for Project Fiona allows all existing PC games to be played right out of the box and also provides game developers new opportunities as they develop next-gen games on a highly-intuitive platform. Both developers and gamers are going to love the new user interface that combines the best of a gamepad, multi-touch screen and accelerometers for an all-new gaming experience on-the-go,” he elaborated.
We admit we are more than a little bit intrigued. It is refreshing to see a company literally approach tablets from a completely different angle. Project Fiona will apparently be made available for purchase towards the late part of this year.
For a clearer look at what Project Fiona has on offer, hit the video below.
Most Read Articles
Have Your Say
What new tech or developments are you most anticipating this year?
New smartphone announcements (5 votes)Technological breakthroughs (9 votes)Launch of new consoles, or notebooks (7 votes)Innovative Artificial Intelligence solutions (4 votes)Biotechnology or medical advancements (10 votes)Better business applications (3 votes)